Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NCI

Antigens, Means And Method For The Diagnosis Of Lymphadenopathy And Acquired Immune Deficiency Syndrome

  • Read more about Antigens, Means And Method For The Diagnosis Of Lymphadenopathy And Acquired Immune Deficiency Syndrome
US Application 06/771,247
Filed on 1985-09-30

Nucleic Acid Probe of Human Immunodeficiency Virus Type 1 (HIV-1), and a Method and Kit Employing this Probe for Detecting the Presence of Nucleic Acid of HIV-1

  • Read more about Nucleic Acid Probe of Human Immunodeficiency Virus Type 1 (HIV-1), and a Method and Kit Employing this Probe for Detecting the Presence of Nucleic Acid of HIV-1
US Patent 8,507,196
Filed on 1993-04-23

Cloned DNA Sequences Related To The Genomic RNA Of lymphadenopathy-associated-virus (LAV) And Proteins Encoded By Said LAV Genomic RNA

  • Read more about Cloned DNA Sequences Related To The Genomic RNA Of lymphadenopathy-associated-virus (LAV) And Proteins Encoded By Said LAV Genomic RNA
US Patent 6,894,152
Filed on 1994-02-25

Diamidine Derivatives As Inhibitors Of Human Tyrosyl-DNA-phosphodiesterase (Tdp1)

  • Read more about Diamidine Derivatives As Inhibitors Of Human Tyrosyl-DNA-phosphodiesterase (Tdp1)
Patent Cooperation Treaty
PCT/US07/007636
Filed on 2007-03-27

TETRACYCLINE COMPOUNDS AND METHODS OF TREATMENT

  • Read more about TETRACYCLINE COMPOUNDS AND METHODS OF TREATMENT
Patent Cooperation Treaty
PCT/US07/007724
Filed on 2007-03-27

IRTA2 ANTIBODIES AND METHODS OF USE

  • Read more about IRTA2 ANTIBODIES AND METHODS OF USE
US Patent 7,999,077
Filed on 2007-03-28

Amino acid DNA sequences related to genomic RNA of human immunodeficiency virus
(HIV-1)

  • Read more about Amino acid DNA sequences related to genomic RNA of human immunodeficiency virus (HIV-1)
US Patent 5,980,900
Filed on 1991-08-28

Vaccinia Virus Expression Vector For Selective Replication In A Tumor Cell And Introduction Of Exogenous Nucleotide Sequence Into A Tumor Cell

  • Read more about Vaccinia Virus Expression Vector For Selective Replication In A Tumor Cell And Introduction Of Exogenous Nucleotide Sequence Into A Tumor Cell
US Patent 8,506,947
Filed on 2007-02-16

DNA sequences and peptides of human immunodeficiency virus (HIV-1

  • Read more about DNA sequences and peptides of human immunodeficiency virus (HIV-1
US Patent 7,119,181
Filed on 1994-09-19

NEF peptide encoded by human immunodefiency virus type 1 (HIV-1)

  • Read more about NEF peptide encoded by human immunodefiency virus type 1 (HIV-1)
US Patent 5,705,612
Filed on 1994-02-14

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 952
  • Page 953
  • Page 954
  • Page 955
  • Page 956
  • Page 957
  • Page 958
  • Page 959
  • Page 960
  • …
  • Next page ››
  • Last page Last »
Subscribe to NCI
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health